Southern Copper Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2018 — Data Talk
Southern Copper Corporation ( SCCO ) is currently at $72.48, down $0.18 or 0.25%
--Would be lowest close since July 11, 2023, when it closed at $72.14
--Currently down 11 of the past 12 days
--Currently down nine consecutive days; down 9.64% over this period
--Longest losing streak since Sept. 11, 2018, when it fell for nine straight trading days
--Worst nine day stretch since the nine days ending May 23, 2023, when it fell 10.55%
--Down 10.14% month-to-date; on pace for worst month since May 2023, when it fell 13.09%
--Up 20.02% year-to-date
--Down 17.11% from its all-time closing high of $87.44 on July 31, 2023
--Up 62.15% from 52 weeks ago (Sept. 28, 2022), when it closed at $44.70
--Down 17.11% from its 52-week closing high of $87.44 on July 31, 2023
--Up 62.15% from its 52-week closing low of $44.70 on Sept. 28, 2022
--Traded as low as $72.03; lowest intraday level since July 11, 2023, when it hit $71.10
--Down 0.87% at today's intraday low
All data as of 12:51:14 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2023 13:08 ET (17:08 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom